Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (30) 30
humans (25) 25
infectious diseases (25) 25
male (21) 21
female (20) 20
adult (19) 19
hiv (19) 19
human immunodeficiency virus--hiv (14) 14
hiv infections - drug therapy (13) 13
cohort studies (12) 12
epidemiology (12) 12
middle aged (12) 12
aids (11) 11
hiv infection (11) 11
antiretroviral therapy (10) 10
europe (10) 10
immunology (10) 10
risk factors (10) 10
infection (9) 9
antiviral agents (8) 8
cd4 lymphocyte count (8) 8
mortality (8) 8
acquired immune deficiency syndrome--aids (7) 7
adolescent (7) 7
analysis (7) 7
europe - epidemiology (7) 7
health aspects (7) 7
hiv infections - diagnosis (7) 7
infections (7) 7
viral load (7) 7
young adult (7) 7
aged (6) 6
aids/hiv (6) 6
anti-hiv agents - therapeutic use (6) 6
antiretroviral drugs (6) 6
care and treatment (6) 6
collaboration (6) 6
combination antiretroviral therapy (6) 6
drug therapy (6) 6
journal article (6) 6
public health (6) 6
time factors (6) 6
anti-retroviral agents - therapeutic use (5) 5
antiretroviral agents (5) 5
cd4 antigen (5) 5
dk/atira/pure/researchoutput/pubmedpublicationtype/d016428 (5) 5
hiv infections - epidemiology (5) 5
human immunodeficiency virus (5) 5
incidence (5) 5
microbiology (5) 5
research support, non-u.s. gov't (5) 5
therapy (5) 5
cd4-positive t-lymphocytes - immunology (4) 4
complications and side effects (4) 4
diagnosis (4) 4
disease (4) 4
disease progression (4) 4
dk/atira/pure/researchoutput/pubmedpublicationtype/d013485 (4) 4
dosage and administration (4) 4
hiv testing (4) 4
life sciences (4) 4
medical diagnosis (4) 4
medicine (4) 4
outcomes (4) 4
prevention (4) 4
ribonucleic acid--rna (4) 4
risk (4) 4
sub-saharan africa (4) 4
surveillance (4) 4
treatment outcome (4) 4
virus diseases (4) 4
acquired immune deficiency syndrome (3) 3
adolescents (3) 3
and commentaries (3) 3
antigens (3) 3
antiretroviral therapy, highly active (3) 3
antiretroviral therapy, highly active - methods (3) 3
articles and commentaries (3) 3
biology and life sciences (3) 3
care (3) 3
child (3) 3
child, preschool (3) 3
cohort (3) 3
cooperative behavior (3) 3
count (3) 3
death (3) 3
digestive system diseases (3) 3
disease transmission (3) 3
guidelines (3) 3
hepatitis (3) 3
hepatitis b (3) 3
hepatitis b virus (3) 3
highly active antiretroviral therapy (3) 3
hiv infections - mortality (3) 3
hiv patients (3) 3
infant (3) 3
medical tests (3) 3
medicine and health sciences (3) 3
multidisciplinary sciences (3) 3
nutrition & dietetics (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)
by Sullivan, Ann K and Raben, Dorthe and Reekie, Joanne and Rayment, Michael and Mocroft, Amanda and Esser, Stefan and Leon, Agathe and Begovac, Josip and Brinkman, Kees and Zangerle, Robert and Grzeszczuk, Anna and Vassilenko, Anna and Hadziosmanovic, Vesna and Krasnov, Maksym and Sönnerborg, Anders and Clumeck, Nathan and Gatell, José and Gazzard, Brian and d'Arminio Monforte, Antonella and Rockstroh, Jürgen and Lundgren, Jens D
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e52845
Improved methods for targeting HIV testing among patients most likely to be infected are required; HIDES I aimed to define the methodology of a European wide... 
Prevalence | Disease | HIV Infections - epidemiology | Humans | Middle Aged | Europe - epidemiology | Male | HIV Seropositivity - diagnosis | Feasibility Studies | Patient Acceptance of Health Care | Diagnostic Tests, Routine - methods | HIV Infections - diagnosis | HIV Seropositivity - epidemiology | Adult | Female | Surveys and Questionnaires | Odds Ratio | Surveys | HIV testing | Medical tests | Sexually transmitted diseases | Disease transmission | HIV (Viruses) | Health care | Drug abuse | Sexually transmitted diseases--STD | Exanthema | Seborrheic dermatitis | Infections | Family medical history | Medical diagnosis | Dermatitis | Hepatitis | Cost effectiveness | Mononucleosis | Human immunodeficiency virus--HIV | Hepatitis B virus | Drug therapy | Indicators | Public health | Thrombocytopenia | Antiretroviral drugs | Herpes zoster | Dysplasia | Leukopenia | Dermatology | Feasibility studies | Cervix | Lymphoma | CD4 antigen | Medicine | Infectious diseases | Hospitals | Hides | Strategy | Cost analysis | Hepatitis B | Cancer | Hälsovetenskap | Medicin och hälsovetenskap | Infektionsmedicin | Medicinska och farmaceutiska grundvetenskaper | Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi | Immunologi inom det medicinska området | Klinisk medicin | STD | HIV | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. How do we optimize HIV testing in Denmark?
by Raben, Dorthe and Lundgren, Jens
Ugeskrift for laeger, 12/2015, Volume 177, Issue 50, p. V67906
Mass Screening | HIV Infections - diagnosis | Humans | Denmark
Journal Article
Details down arrow
3. Hvordan optimerer vi hiv-testning i Danmark?
by Raben, Dorthe and Lundgren, Jens
Ugeskrift for laeger, 12/2015, Volume 177, Issue 50, p. V67906
Journal Article
Details down arrow
4. Full Text Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
by Rodger, Alison J and Cambiano, Valentina and Bruun, Tina and Vernazza, Pietro and Collins, Simon and Degen, Olaf and Corbelli, Giulio Maria and Estrada, Vicente and Estrada, Vicente P and Geretti, Anna Maria and Beloukas, Apostolos and Raben, Dorthe and Coll, Pep and Antinori, Andrea and Nwokolo, Nneka and Rieger, Armin and Prins, Jan M and Prins, Jan and Blaxhult, Anders and Weber, Rainer and Van Eeden, Arne and Brockmeyer, Norbert and Brockmeyer, Norbert H and Clarke, Amanda and del Romero Guerrero, Jorge and Raffi, Francois and Bogner, Johannes R and Bogner, Johannes and Wandeler, Gilles and Gerstoft, Jan and Gutiérrez, Felix and Brinkman, Kees and Kitchen, Maria and Ostergaard, Lars and Leon, Agathe and Ristola, Matti and Jessen, Heiko and Jessen, Arne and Stellbrink, Hans-Jürgen and Phillips, Andrew N and Lundgren, Jens and Cobarsi, Patricia and Nieto, Aroa and Meulbroek, Michael and Carrillo, Antonia and Saz, Jorge and Guerrero, Jorge D.R and García, Mar Vera and Masiá, Mar and Robledano, Catalina and Leal, Lorna and Redondo, Eva G and Marquez, Rocio and Sandoval, Raquel and Viciana, Pompeyo and Espinosa, Nuria and Lopez-Cortes, Luis and Podzamczer, Daniel and Tiraboschi, Juan and Morenilla, Sandra and Antela, Antonio and Losada, Elena and Sewell, Janey and Kirk, Sarah and Knott, Alyson and Fernandez, Thomas and Gompels, Mark and Jennings, Louise and Ward, Lana and Fox, Julie and Lwanga, Julianne and Lee, Ming and Gilson, Richard and Leen, Clifford and Morris, Sheila and Clutterbuck, Dan and Brady, Michael and Asboe, David and Fedele, Serge and Fidler, Sarah and Potthoff, Anja and Skaletz-Rorowski, Adriane and Seybold, Ulrich and Roider, Julia and Ruzicic, Slobodan and Kümmerle, Tim and Lehmann, Clara and Bartel, Sindy and Hüfner, Anja and Rockstroh, Jürgen and Mohrmann, Karina and Boesecke, Christoph and Krznaric, Ivanka and Ingiliz, Patrick and Grube, Christina and Braun, Dominique and Günthard, Huldrych and Furrer, Hansjakob and Rauch, Andri and Schmid, Patrick and ... and PARTNER Study Grp and PARTNER Study Group
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10189, pp. 2428 - 2438
The level of evidence for HIV transmission risk through condomless sex in serodifferent gay couples with the HIV-positive partner taking virally suppressive... 
VIRAL LOAD | MEDICINE, GENERAL & INTERNAL | RNA | HETEROSEXUAL TRANSMISSION | BLOOD-PLASMA | SEMEN | PREVENTION | INFECTION | SERODISCORDANT COUPLES | HIV patients | Disease transmission | HIV (Viruses) | Gay couples | Risk factors | Therapy | Sexually transmitted diseases--STD | Prophylaxis | Sex | Risk | Partnerships | Infections | Phylogeny | Incidence | Mathematical analysis | Antiretroviral agents | Human immunodeficiency virus--HIV | Drug therapy | Anal sex | Antiretroviral drugs | Sexual behavior | Health risks | Exposure | Ribonucleic acid--RNA | Seroconversion | Antiretroviral therapy | Studies | Data collection | Gays & lesbians | Condoms
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Late presentation of chronic viral hepatitis for medical care: A consensus definition
by Mauss, Stefan and Pol, Stanislas and Buti, Maria and Duffell, Erika and Gore, Charles and Lazarus, Jeffrey V and van der Grient, Hilje Logtenberg and Lundgren, Jens and Mozalevskis, Antons and Raben, Dorthe and Schatz, Eberhard and Wiktor, Stefan and Rockstroh, Jürgen K and Veldhuijzen, Irene and Dedes, Nikos and Gatell, José and West, Brian and Casabona, Jordi and European consensus working grp and European consensus working group on late presentation for Viral Hepatitis Care and on behalf of the European consensus working group on late presentation for Viral Hepatitis Care
BMC Medicine, ISSN 1741-7015, 05/2017, Volume 15, Issue 1, pp. 92 - 5
Introduction: We present two consensus definitions of advanced and late stage liver disease being used as epidemiological tools. These definitions can be... 
Viral hepatitis | Late presentation | Testing | EUROPE | MEDICINE, GENERAL & INTERNAL | LIVER FIBROSIS | DISEASE | APRI | RISK | FIB-4 | Liver Cirrhosis - diagnosis | Liver Cirrhosis - virology | Time Factors | Europe | Humans | Middle Aged | Female | Male | Hepatitis B, Chronic - diagnosis | Hepatitis C, Chronic - diagnosis | Consensus | Health care | Working groups | Liver | Medical services | Viruses | Hepatocellular carcinoma | Infections | Epidemiology | Bleeding | Hepatitis | Liver cancer | Encephalopathy | Human immunodeficiency virus--HIV | Gastroenterology | Hepatitis B virus | Public health | Jaundice | Antigens | Liver diseases | Patients | Morbidity | Cirrhosis | Surveillance | Biopsy | Collaboration | Fibrosis | Interferon | Ascites | Liver cirrhosis | Hepatic encephalopathy | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Cohort profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
by Chêne, Geneviève and Phillips, Andrew and Costagliola, Dominique and Sterne, Jonathan A.C and Furrer, Hansjakob and del Amo, Julia and Mocroft, Amanda and Monforte, Antonella d'Arminio and Dabis, François and Miro, José M and Barger, Diana and Termote, Monique and Schwimmer, Christine and Brandt, Rikke Salbøl and Friis-Moller, Nina and Raben, Dorthe and Haerry, David and Egger, Matthias and Weller, Ian and De Wit, Stéphane
International Journal of Epidemiology, ISSN 0300-5771, 06/2017, Volume 46, Issue 3, pp. 797 - 797
Many questions about the long-term effects of combination antiretroviral therapy (cART) on clinical outcomes in people living with HIV (PLWH) and their impact... 
MORTALITY | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ADULTS | AIDS | DEATH | COMBINATION ANTIRETROVIRAL THERAPY | TRENDS | CLASS VIROLOGICAL FAILURE | Anti-Retroviral Agents - therapeutic use | Epidemiologic Studies | HIV-1 - drug effects | HIV Infections - epidemiology | Humans | Cooperative Behavior | Europe - epidemiology | Male | Treatment Outcome | CD4 Lymphocyte Count | HIV Infections - diagnosis | Adult | Female | HIV Infections - drug therapy | Antiretroviral Therapy, Highly Active - methods | Cohort Studies | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases | observational epidemiology | HIV | cohort collaboration | prognosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Defining linkage to care following human immunodeficiency virus (HIV) diagnosis for public health monitoring in Europe
by Croxford, Sara and Croxford, Sara and Raben, Dorthe and Jakobsen, Stine F and Burns, Fiona and Copas, Andrew and Brown, Alison E and Delpech, Valerie C and On Behalf Of OptTEST By Hiv In Europe, Behalf Of OptTEST By Hiv In Europe and OptTEST HIV Europe and on behalf of OptTEST by HIV in Europe
Eurosurveillance, ISSN 1025-496X, 11/2018, Volume 23, Issue 48, pp. 21 - 25
Prompt linkage to human immunodeficiency virus (HIV) care after diagnosis is crucial to ensure optimal patient outcomes. However, few countries monitor this... 
public health terms | epidemiology | human immunodeficiency virus - HIV | surveillance | INFECTIOUS DISEASES | RETENTION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text The use of glycaemic index tables to predict glycaemic index of composite breakfast meals
by Flint, Anne and Møller, Bente K and Raben, Anne and Pedersen, Dorthe and Tetens, Inge and Holst, Jens J and Astrup, Arne
British Journal of Nutrition, ISSN 0007-1145, 6/2004, Volume 91, Issue 6, pp. 979 - 989
The applicability of the glycaemic index (GI) in the context of mixed meals and diets is still debatable. The objective of the present study was to investigate... 
Macronutrients | Glucose | Energy | Insulin | DEPENDENT DIABETES-MELLITUS | glucose | insulin | LOAD | POSTPRANDIAL GLUCOSE | IMPAIRED GLUCOSE-TOLERANCE | FOODS | INSULIN RESPONSES | NUTRITION & DIETETICS | DIETARY CARBOHYDRATE | DISEASE | MIXED MEALS | PLASMA-GLUCOSE | macronutrients | energy | Dietary Fats - metabolism | Humans | Male | Dietary Carbohydrates - metabolism | Insulin - blood | Bread | Dietary Proteins - metabolism | Animals | Glycemic Index - physiology | Adult | Edible Grain | Energy Metabolism - physiology | Food | Milk
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study-2012-2015
by Raben, D and Sullivan, AK and Mocroft, A and Kutsyna, G and Hadziosmanovic, V and Vassilenko, A and Chkhartisvili, N and Mitsura, V and Pedersen, C and Anderson, J and Begovac, J and Dragsted, UB and Bertisch, B and Grzeszczuk, A and Minton, J and Necsoi, VC and Kitchen, M and Ajana, F and Sokhan, A and Comi, L and Farazmand, P and Pesut, D and De Wit, S and Gate, JM and Gazzard, B and Monforte, AD and Rockstroh, JK and Yazdanpanah, Y and Champenois, K and Jakobsen, ML and Lundgren, JD and Clumeck, N and Gatell, J and Lundgren, J and Rockstroh, J and Zangerle, R and Necsoi, C and Genotte, AF and Redder, L and Caby, F and Bouvet, E and Khuong, MA and Caldato, S and Morlat, P and Coban, D and Arvieux, C and Cabie, A and Chkhartishvili, N and Gerdes, S and Sambatakou, H and Sthoeger, ZM and Elbirt, D and Bini, T and Celesia, BM and Gussio, M and Brinkman, K and Rosca, EC and Sanchez, MAG and Estrada, VP and Gonzalez, EO and Ocampo, A and Masia, M and Agusti, C and Sonnerborg, A and Vernazza, P and Sullivan, A and Rayment, M and Rae, C and Foxton, M and Morris, S and Palfreeman, A and Calderwood, J and Ong, ELC and Mummery, D and Kuznetsova, A and Hansen, EW and HIDES Study Grp and HIDES Study Group and on behalf of the HIDES Study Group
PLOS ONE, ISSN 1932-6203, 08/2019, Volume 14, Issue 8, p. e0220108
Background It is cost-effective to perform an HIV test in people with specific indicator conditions (IC) with an undiagnosed HIV prevalence of at least 0.1%.... 
MULTIDISCIPLINARY SCIENCES | CARE | HIV testing | Economic aspects | Diagnosis | HIV infection | Statistics | Methods | HIV (Viruses) | Analysis | Thrombocytopenia | Leukopenia | Infections | Regression analysis | Infectious mononucleosis | Lymphadenopathy | Hepatitis | Infectious diseases | Hospitals | Acquired immune deficiency syndrome--AIDS | Mononucleosis | Collaboration | Human immunodeficiency virus--HIV | Hides | Medical tests | Lymphomas | Public health | Cancer | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis
by Willemse, Sophie and Smit, Colette and Sogni, Philippe and Sarcletti, Mario and Uberti-Foppa, Caterina and Wittkop, Linda and Raben, Dorthe and D'Arminio Monforte, Antonella and Dabis, Francois and van der Valk, Marc and Judd, Ali and Zangerle, Robert and Touloumi, Giota and Warszawski, Josiane and Meyer, Laurence and Dabis, François and Murielle, M and Ghosn, Jade and Leport, Catherine and Reiss, Peter and Wit, Ferdinand and Prins, Maria and Bucher, Heiner and Gibb, Diana and Fätkenheuer, Gerd and Obel, Niels and Thorne, Claire and Mocroft, Amanda and Kirk, Ole and Stephan, Christoph and Pérez-Hoyos, Santiago and Hamouda, Osamah and ClinSurv, German and Bartmeyer, Barbara and Chkhartishvili, Nikoloz and Noguera-Julian, Antoni and Antinori, Anea and Brockmeyer, Norbert and Prieto, Luis and Pablo, R and Soriano-Arandes, Antoni and Battegay, Manuel and Kouyos, Roger and Mussini, Cristina and Tookey, Pat and Casabona, Jordi and Miró, Jose M and Castagna, Antonella and Hepatocellular Carcinoma Screening Project Working Group for the Collaboration of Observational HIV on behalf of Epidemiological Research Europe (COHERE) In EuroCoord
Journal of viral hepatitis, ISSN 1352-0504, 2019, Volume 26, Issue 10, pp. 1224 - 1228
cancer screening | chronic viral hepatitis | guideline adherence | co‐infection | hepatocellular carcinoma screening | human immunodeficiency virus | hepatocellular carcinoma | liver cirrhosis | co-infection | Short Communications | Short Communication
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. HIV post-test practices: An online survey examining perceived delivery of HIV test results, post-test discussion and referral in healthcare settings across the WHO European Region
by Bell, Stephen and Casabona, Jordi and Tsereteli, Nino and Raben, Dorthe and De Wit, John
Sexual Health, ISSN 1448-5028, 2016, Volume 13, Issue 3, pp. 205 - 212
Background: The aim of this study was to assess perceptions of health professionals involved in HIV testing policy and practice in national settings across the... 
INFECTIOUS DISEASES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | TIME | GUIDELINES | Prevention | Studies | Perceptions | Medical tests | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
Details down arrow
12. Full Text Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
by Smit, Colette and Arends, Joop and Peters, Lars and Montforte, Antonella d'Arminio and Dabis, Francois and Zangerle, Robert and Daikos, George and Mussini, Christina and Mallolas, Josep and de Wit, Stephane and Zinkernagel, Annelies and Cosin, Jaime and Chene, Genevieve and Raben, Dorthe and Rockstroh, Jürgen and Hepatitis C-Working Grp COHERE and Hepatitis C- working group for COHERE in Eurocoord and For the Hepatitis C- working group for COHERE in Eurocoord
BMC Infectious Diseases, ISSN 1471-2334, 11/2015, Volume 15, Issue 1, p. 498
Background: Contradicting results on the effect of abacavir (ABC) on hepatitis C virus (HCV) treatment responses in HIV/HCV co-infected patients have been... 
HCV treatment | HCV treatment response | Abacavir | HCV/HIV co-infection | HIV-HCV | MORTALITY | INFECTIOUS DISEASES | VIRUS-INFECTION | CHRONIC HEPATITIS-C | COMBINATION | COINFECTED PATIENTS | THERAPY | PREDICT | PEGYLATED INTERFERON | INTERFERON PLUS RIBAVIRIN | Hepacivirus - drug effects | Recombinant Proteins - therapeutic use | Emtricitabine - therapeutic use | Hepatitis C - drug therapy | Tenofovir - therapeutic use | Coinfection - drug therapy | Europe | Humans | Middle Aged | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Hepacivirus - genetics | Male | Polyethylene Glycols - therapeutic use | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Zidovudine - therapeutic use | Dideoxynucleosides - therapeutic use | Reverse Transcriptase Inhibitors - therapeutic use | Drug Combinations | Cohort Studies | Complications and side effects | Antiviral agents | Care and treatment | Analysis | Interferon | Research | Health aspects | HIV infection | Infectious diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs
by Anderegg, Nanina and Panayidou, Klea and Abo, Yao and Alejos, Belen and Althoff, Keri N and Anastos, Kathryn and Antinori, Anea and Balestre, Eric and Becquet, Renaud and Castagna, Antonella and Castelnuovo, Barbara and Chêne, Geneviève and Coelho, Lara and Collins, Intira Jeannie and Costagliola, Dominique and Crabtree-Ramírez, Brenda and Dabis, Francois and D'Arminio Monforte, Antonella and Davies, Mary-Ann and de Wit, Stéphane and Delpech, Valérie and de La Mata, Nicole L and Duda, Stephany and Freeman, Aimee and Gange, Stephen J and Grabmeier-Pfistershammer, Katharina and Gunsenheimer-Bartmeyer, Barbara and Jiamsakul, Awachana and Kitahata, Mari M and Law, Matthew and Manzardo, Christian and McGowan, Catherine and Meyer, Laurence and Moore, Richard and Mussini, Cristina and Nakigoz, Gertrude and Nash, Denis and tek Ng, Oon and Obel, Niels and Pantazis, Nikos and Poda, Armel and Raben, Dorthe and Reiss, Peter and Riggen, Larry and Sabin, Caroline and d'Amour Sinayobye, Jean and Sönnerborg, Anders and Stoeckle, Marcel and Thorne, Claire and Torti, Carlo and IeDEA COHERE Cohort Collaborations and IeDEA and COHERE Cohort Collaborations and The IeDEA and COHERE Cohort Collaborations
Clinical infectious diseases, ISSN 1058-4838, 2018, Volume 66, Issue 6, pp. 893 - 903
Early initiation of combination antiretroviral therapy (cART), at higher CD4 cell counts, prevents disease progression and reduces sexual transmission of human... 
CD4 cell count | WHO guidelines | antiretroviral therapy | COHORT PROFILE | INFECTIOUS DISEASES | ADVANCED HIV DISEASE | SUB-SAHARAN AFRICA | INITIATION | GUIDELINES | MICROBIOLOGY | IMMUNOLOGY | CARE | INTERNATIONAL EPIDEMIOLOGIC DATABASES | EVALUATE AIDS IEDEA | and Commentaries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text HIV pre-test practices: an online survey examining perceptions of informed consent and pre-test information delivery in health care settings across the WHO European Region
by Bell, Stephen and Casabona, Jordi and Tsereteli, Nino and Raben, Dorthe and de Wit, John
International Journal of STD & AIDS, ISSN 0956-4624, 5/2017, Volume 28, Issue 6, pp. 558 - 563
The objective of this study was to gather health professionals’ perceptions about gaining informed consent and delivering HIV pre-test information. An online... 
HIV | informed consent | pre-test information | Europe | INFECTIOUS DISEASES | GUIDANCE | IMMUNOLOGY | Young Adult | Informed Consent | World Health Organization | Delivery of Health Care - methods | HIV Infections - diagnosis | Humans | Middle Aged | Adult | Female | Male | Aged
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery
by Engsig, Frederik N and Zangerle, Robert and Katsarou, Olga and Dabis, Francois and Reiss, Peter and Gill, John and Porter, Kholoud and Sabin, Caroline and Riordan, Anew and Fätkenheuer, Gerd and Gutiérrez, Félix and Raffi, Francois and Kirk, Ole and Mary-Krause, Murielle and Stephan, Christoph and de Olalla, Patricia Garcia and Guest, Jodie and Samji, Hasina and Castagna, Antonella and D'Arminio Monforte, Antonella and Skaletz-Rorowski, Aiane and Ramos, Jose and Lapadula, Giuseppe and Mussini, Cristina and Force, Lluís and Meyer, Laurence and Lampe, Fiona and Boufassa, Faroudy and Bucher, Heiner C and de Wit, Stéphane and Burkholder, Greer A and Teira, Ramon and Justice, Amy C and Sterling, Tim R and M Crane, Heidi and Gerstoft, Jan and Grarup, Jesper and May, Margaret and Chêne, Geneviève and Ingle, Suzanne M and Sterne, Jonathan and Obel, Niels and Burkholder, Greer and Justice, Amy and R Sterling, Tim and Crane, Heidi M and Boulle, Anew and Brodt, Hans-Reinhard and Wit, Ferdinand and Prins, Maria and ART-CC and COHERE EuroCoord and Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord and for the Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Clinical infectious diseases, ISSN 1058-4838, 2014, Volume 58, Issue 9, pp. 1312 - 1321
Some human immunodeficiency virus (HIV)-infected individuals initiating combination antiretroviral therapy (cART) with low CD4 counts achieve viral suppression... 
mortality | CD4 cell recovery | risk factors | sustained viral suppression | HIV | INFECTIOUS DISEASES | INITIATION | PROGNOSIS | COLLABORATIVE ANALYSIS | INCREASES | AIDS | MICROBIOLOGY | IMMUNOLOGY | VIROLOGICAL RESPONSE | ACTIVE ANTIRETROVIRAL THERAPY | INFECTION | CELL COUNT | IMMUNODEFICIENCY | Heterosexuality | Humans | Middle Aged | Risk Factors | Logistic Models | Male | CD4 Lymphocyte Count | Cause of Death | Substance-Related Disorders - complications | Viral Load | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | HIV Infections - transmission | Cohort Studies | Logistic regression | Care and treatment | Usage | Mortality | Analysis | HIV (Viruses) | Risk factors